Did you know?
Multiple sclerosis is the most common degenerative neurological condition diagnosed in young adults, with over 75% of people diagnosed under the age of 40.
LED upgrade lighting for Wilson facility
LED upgrade lighting for Wilson facilityRead more
Lemtrada (Alemtuzumab) recommended for the Pharmaceutical Benefits Scheme
Alemtuzumab, to be marketed as Lemtrada, is the latest drug treatment for people with relapsing remitting MS. It was approved by the National Health Service in the UK, and we have just received news that it has recently been positively recommended by the Pharmaceutical Benefits Advisory Committee (PBAC) in Australia for the Pharmaceutical Benefits Scheme (PBS) subsidy.Read more
Yoga and Multiple Sclerosis
Yoga has become one of the most popular forms of exercise in the world and MSWA has been making regular classes available to its Members since 2012. Read how yoga is helping those with multiple sclerosis live healthier lives - combining mind, body and spirit, in the search for balance and health.Read more
Perth Members Forum Wrap Up 2014
Summary of Perth Members Forum presentations 4.6.14Read more
Where does the money go?
Without your contribution, we couldn't continue to provide services to thousands of Western Australians with MS.